Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease

Atherosclerosis

Volumn 265, Issue , 2017, Pages 35-40

  Wada, Hideki ^a   Dohi, Tomotaka ^a   Miyauchi, Katsumi ^a   Shitara, Jun ^a   Endo, Hirohisa ^a   Doi, Shinichiro ^a   Konishi, Hirokazu ^b   Naito, Ryo ^c   Tsuboi, Shuta ^b   Ogita, Manabu ^b   Kasai, Takatoshi ^a   Hassan, Ahmed ^a,d   Okazaki, Shinya ^a   Isoda, Kikuo ^a   Suwa, Satoru ^b   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^d Suez Canal University Faculty of Medicine   (Egypt)

Author keywords

Atherosclerosis; Coronary artery disease; Inflammation

Indexed keywords

AGED; ARTICLE; CLINICAL OUTCOME; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DEATH; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL LYMPHOCYTE RATIO; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; BLOOD; CAUSE OF DEATH; CHI SQUARE DISTRIBUTION; KAPLAN MEIER METHOD; LYMPHOCYTE; LYMPHOCYTE COUNT; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHIL; PROPORTIONAL HAZARDS MODEL; STATISTICAL MODEL; TIME FACTOR; TREATMENT OUTCOME;

AGED; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; LOGISTIC MODELS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85027969279     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2017.08.007     Document Type: Article

References (31)

1. Ridker, P.M., Cushman, M., Stampfer, M.J., Tracy, R.P., Hennekens, C.H., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997), 973–979.
2. Horne, B.D., Anderson, J.L., John, J.M., Weaver, A., Bair, T.L., et al. Which white blood cell subtypes predict increased cardiovascular risk?. J. Am. Coll. Cardiol. 45 (2005), 1638–1643.
3. Rocha, N.P., Fortes, R.C., Total lymphocyte count and serum albumin as predictors of nutritional risk in surgical patients. Arq. Bras. Cir. Dig. 28 (2015), 193–196.
4. Azab, B., Chainani, V., Shah, N., McGinn, J.T., Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study. Angiology 64 (2013), 456–465.
5. Benites-Zapata, V.A., Hernandez, A.V., Nagarajan, V., Cauthen, C.A., Starling, R.C., et al. Usefulness of neutrophil-to-lymphocyte ratio in risk stratification of patients with advanced heart failure. Am. J. Cardiol. 115 (2015), 57–61.
6. Bowen, R.C., Little, N.A.B., Harmer, J.R., Ma, J., Mirabelli, L.G., et al. Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis. Oncotarget 9 (2017), 32171–32189.
7. Ethier, J.L., Desautels, D., Templeton, A., Shah, P.S., Amir, E., Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis. Breast Cancer Res. BCR, 19, 2017, 2.
8. Sabatine, M.S., Morrow, D.A., Cannon, C.P., Murphy, S.A., Demopoulos, L.A., et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J. Am. Coll. Cardiol. 40 (2002), 1761–1768.
9. Salciccioli, J.D., Marshall, D.C., Pimentel, M.A., Santos, M.D., Pollard, T., et al. The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study. Crit. Care, 19, 2015, 13 (London, England).
10. Cho, K.I., Ann, S.H., Singh, G.B., Her, A.Y., Shin, E.S., Combined usefulness of the platelet-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio in predicting the long-term adverse events in patients who have undergone percutaneous coronary intervention with a drug-eluting stent. PLoS One, 10, 2015, e0133934.
11. Borekci, A., Gur, M., Turkoglu, C., Baykan, A.O., Seker, T., et al. Neutrophil to lymphocyte ratio predicts left ventricular remodeling in patients with ST elevation myocardial infarction after primary percutaneous coronary intervention. Korean Circ. J. 46 (2016), 15–22.
12. Kaya, M.G., Akpek, M., Lam, Y.Y., Yarlioglues, M., Celik, T., et al. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: a prospective, multicenter study. Int. J. Cardiol. 168 (2013), 1154–1159.
13. Park, J.J., Jang, H.J., Oh, I.Y., Yoon, C.H., Suh, J.W., et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am. J. Cardiol. 111 (2013), 636–642.
14. Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., et al. Diagnostic criteria for dyslipidemia. J. Atheroscler. Thromb. 20 (2013), 655–660.
15. Avanzas, P., Quiles, J., Lopez de Sa, E., Sanchez, A., Rubio, R., et al. Neutrophil count and infarct size in patients with acute myocardial infarction. Int. J. Cardiol. 97 (2004), 155–156.
16. Eriksson, E.E., Xie, X., Werr, J., Thoren, P., Lindbom, L., Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J. Official Publ. Fed. Am. Soc. Exp. Biol. 15 (2001), 1149–1157.
17. Hotchkiss, R.S., Karl, I.E., The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348 (2003), 138–150.
18. Onsrud, M., Thorsby, E., Influence of in vivo hydrocortisone on some human blood lymphocyte subpopulations. I. Effect on natural killer cell activity. Scand. J. Immunol. 13 (1981), 573–579.
19. Han, Y.C., Yang, T.H., Kim, D.I., Jin, H.Y., Chung, S.R., et al. Neutrophil to lymphocyte ratio predicts long-term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ. J. 43 (2013), 93–99.
20. Balta, S., Celik, T., Mikhailidis, D.P., Ozturk, C., Demirkol, S., et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin. Appl. Thromb. Hemost. 22 (2016), 405–411.
21. Soylu, K., Yuksel, S., Gulel, O., Erbay, A.R., Meric, M., et al. The relationship of coronary flow to neutrophil/lymphocyte ratio in patients undergoing primary percutaneous coronary intervention. J. Thorac. Dis. 5 (2013), 258–264.
22. Papa, A., Emdin, M., Passino, C., Michelassi, C., Battaglia, D., et al. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin. Chimica Acta; Int. J. Clin. Chem. 395 (2008), 27–31.
23. Wang, X., Zhang, G., Jiang, X., Zhu, H., Lu, Z., et al. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis 234 (2014), 206–213.
24. Arbel, Y., Finkelstein, A., Halkin, A., Birati, E.Y., Revivo, M., et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis 225 (2012), 456–460.
25. Sen, N., Afsar, B., Ozcan, F., Buyukkaya, E., Isleyen, A., et al. The neutrophil to lymphocyte ratio was associated with impaired myocardial perfusion and long term adverse outcome in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Atherosclerosis 228 (2013), 203–210.
26. Ozturk, C., Balta, S., Balta, I., Demirkol, S., Celik, T., et al. Neutrophil-lymphocyte ratio and carotid-intima media thickness in patients with Behcet disease without cardiovascular involvement. Angiology 66 (2015), 291–296.
27. Park, B.J., Shim, J.Y., Lee, H.R., Lee, J.H., Jung, D.H., et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clin. Chimica Acta; Int. J. Clin. Chem. 412 (2011), 925–929.
28. Solak, Y., Yilmaz, M.I., Sonmez, A., Saglam, M., Cakir, E., et al. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin. Exp. Nephrol. 17 (2013), 532–540.
29. Akin, F., Ayca, B., Kose, N., Sahin, I., Akin, M.N., et al. Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia. Angiology 64 (2013), 621–625.
30. Fici, F., Celik, T., Balta, S., Iyisoy, A., Unlu, M., et al. Comparative effects of nebivolol and metoprolol on red cell distribution width and neutrophil/lymphocyte ratio in patients with newly diagnosed essential hypertension. J. Cardiovasc. Pharmacol. 62 (2013), 388–393.
31. Wang, R., Chen, P.J., Chen, W.H., Diet and exercise improve neutrophil to lymphocyte ratio in overweight adolescents. Int. J. sports Med. 32 (2011), 982–986.